Edwards Lifesciences Corp
NYSE:EW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edwards Lifesciences Corp
NYSE:EW
|
US |
|
O
|
Oracle Corp Japan
XMUN:OCJ
|
JP |
|
C
|
CSW Industrials Inc
F:UCI
|
US |
|
Hofseth Biocare ASA
OSE:HBC
|
NO |
|
A
|
Agricultural Bank of China Ltd
XMUN:EK7
|
CN |
|
C
|
Cigna Group
XMUN:CGN
|
US |
|
C
|
Columbus McKinnon Corp
XBER:VC3
|
US |
|
China Resources Cement Holdings Ltd
F:C44
|
HK |
|
Guanajuato Silver Company Ltd
F:E35
|
CA |
|
I
|
IONOS Group SE
F:IOS
|
DE |
|
Palatin Technologies Inc
F:PTN
|
US |
|
King Copper Discovery Corp
XTSX:KCP
|
CA |
|
Companhia Energetica do Ceara
BOVESPA:COCE3
|
BR |
Wall St Price Targets
EW Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EW is 97.94 USD with a low forecast of 85.85 USD and a high forecast of 115.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EW's stock price target?
Price Target
97.94
USD
According to Wall Street analysts, the average 1-year price target for EW is 97.94 USD with a low forecast of 85.85 USD and a high forecast of 115.5 USD.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.
